Genetic background and clinical characteristics of infantile hyperammonemia

Abstract

Background: This study was conducted to analyze the genetic spectrum and clinical characteristics of infantile hyperammonemia. Methods:Between January 2016 and June 2020, we retrospectively enrolled infantile hyperammonemia patients with definitive genetic diagnosis at the Children's Hospital of Fudan University. Based on the age of hyperammonemia onset, patients were grouped into neonatal and post-neonatal subgroups to compare their genetic and clinical features.Results: Collectively, 136 pathogenic or likely pathogenic variants of the 33 genes were identified.Fourteen genes were reported with hyperammonemia (42%, 14/33), with SLC25A13 and MUT being the top two detected genes. In contrast, 19 genes, which have not been previously reported with hyperammonemia, were detected (58%, 19/33), in which JAG1 and ABCC8 were the most frequently mutated genes. Compared with post-neonatal hyperammonemia, neonatal patients with hyperammonemia presented with higher rates of organic acidemia (P=0.001) and fatty acid oxidation disorder (P=0.006), but a lower rate of cholestasis (P<0.001). Patients with neonatal hyperammonemia had a higher ratio of peak plasma ammonia level ≥500 μmol/L (P=0.003) and were more likely to receive precision medicine (P=0.027); however, they had a refractory clinical course (P=0.001) and poorer prognosis than the infantile group.Conclusions: There were significant differences in the genetic spectrum, clinical features, clinical course, and outcomes between infants with different hyperammonemia onset ages.

Hyperammonemia and inborn errors of metabolism

“…As confirmed by Li et al the most common genetic disorders leading to hyperammonemia in their cohort were cholestasis related disorders, urea cycle disorders and organic acidemias ( 10 ). The latter two groups are often linked, as organic acids are regulators of essential enzymes such as N-acetylglutamate synthase ( 11 ).…”